NEW YORK, NY / ACCESSWIRE / September 30, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed in the
United States District Court for the Northern District of California against SolarCity Corporation (“SolarCity” or the “Company”) (NASDAQ: SCTY) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased SolarCity securities between May 5, 2015 through February 9,
2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

On October 29, 2015, SolarCity revealed that it was lowering its full year 2015 guidance. Following this news, SolarCity dropped $8.42 per share, or 22%, to close at $29.65 on October 30, 2015. Then, on February 9, 2016 SolarCity also said that it did not meet its previously issued fiscal year 2015 installation guidance. Following this news, SolarCity dropped $7.72 per share, or 29%, to close at $18.63 on February 10, 2016.

The complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose: (1) that the market demand for SolarCity’s products was diminishing; (2) that SolarCity was hiding this information from the investing public; and (3) consequently, Defendants’ statements about SolarCity’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/scty or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in SolarCity you have until October 14, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 446141

Uniquely Positioned in BitTorrent

NEW YORK, NY / ACCESSWIRE / September 30, 2016 / PeerLogix, Inc. (the “Company”) (OTC Markets: LOGX), an advertising technology and data aggregation provider, today announced that it has been highlighted in a report by Sylva International (http://sylvacap.com).

The report, which could be read in its entirety at: http://sylvacap.com/jewel-mining-internet, discusses PeerLogix positioning and deployments in torrent data. Quoting the writer, “Peerlogix has the ability to mine and harvest an extremely broad range of consumer data (including torrent data), and provide a holistic view of the marketplace to a large group of interested parties. Peerlogix announced on September 20, 2016 that it’s signed a multi-year licensing agreement to deploy its full suite of services to a leading financial services firm. The agreement is for Peerlogix to serve as the financial services firm’s exclusive marketing partner running campaigns in the U.S. and abroad. With this transformational agreement, Peerlogix received considerable third party validation. The Company stated it is now positioned for profitability, to generate cash flow and create shareholder value. This caught our attention.”

Sylva International is a digital platform from which up and coming, as well as established, newsletter writers may leverage our digital expertise in order to build out an investor following. In addition, Sylva International utilizes its network of newsletter writers and its proprietary digital marketing platform to create awareness for companies and their products, both public and private.

About PeerLogix

PeerLogix is an advertising technology and data aggregation company providing a proprietary software as a service, or SAAS, platform which enables the tracking and cataloguing of over-the-top viewership and listenership in order to determine consumer trends and preferences based upon media consumption. PeerLogix’s patent pending platform collects over-the-top data, including IP addresses of the streaming and downloading parties (e.g., location), the name, media type (whether movie, television, documentary, music, e-books, software, etc.), and genre of media watched, listened or downloaded, and utilizes licensed and publicly available demographic and other databases to further filter the collected data to provide insights into consumer preferences to digital advertising firms, product and media companies, entertainment studios and others.

Forward Looking Statement

Certain of the statements contained in this herein include future expectations, contain projections of results of operations or financial condition or state other “forward-looking” information. The information contained in this includes some statements that are not purely historical and contain “forward-looking statements,” as defined by the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Such forward-looking statements include, but are not limited to, statements regarding the Company’s and its management’s expectations, hopes, beliefs, intentions or strategies regarding the future, including the Company’s financial condition and results of operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “should,” “could,” “will,” “plan,” “future,” “continue,” and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, the actual results could differ materially from the forward-looking statements contained in PeerLogix forward-looking statements.

Contact:
William Gorfein
Chief Executive Officer
PeerLogix, Inc.
(646) 598-4640
info@peerlogix.com

SOURCE: PeerLogix, Inc.

ReleaseID: 446312

VANCOUVER, BC / ACCESSWIRE / September 30, 2016 / Marapharm Ventures Inc. (the “Company” or “Marapharm”) Marapharm is pleased to announce that as part of the Corporation’s long-term strategy to maximize shareholder value that the board has implemented a dividend policy as of today’s date. The payment of future cash dividends is subject to the Board’s determination to react to actual future market conditions in the interest of Marapharm. Linda Sampson, the company’s CEO, states that, “this policy implementation is yet another sign that the company is optimistic about its prospects and is excited by this policy addition, as it defines how our shareholders will be rewarded in the future for their loyalty.”

Linda Sampson, CEO, director, has exercised 400,000 share purchase options with a strike-price of $0.50 for total proceeds to the company of $200,000.

At the Company’s Annual General Meeting (the “Meeting”) held on September 16, 2016, Linda Sampson, Corey Klassen, and Yari Nieken were elected as directors of the Company and Saturna Group Chartered Accountants LLP were re-appointed as auditors of the Company for the ensuing year. The shareholders also approved the Company’s 10% rolling stock option plan. There are 3,000,000 shares reserved for issuance under the stock option plan (the “Plan”). The Company has granted stock options to purchase 3,000,000 common shares of the Company at an exercise price of $0.50 per share exercisable in whole or in part for a period of 2 years from the date of grant.

Officers

Chief Executive Officer: Linda Sampson
Chief Financial Officer: Corey Klassen

Audit Committee

Linda Sampson
Corey Klassen
Yari Nieken

In addition, the Company is pleased to announce that it has engaged Pioneer Ventures Inc., Solar Properties Ltd., and Hilltop Business Center Inc. to provide various investor relations services to the Company. Pioneer Ventures Inc., Solar Properties Ltd., and Hilltop Business Center Inc. are Vancouver-based firms that provide advice and assistance on financings and access to capital markets. Pursuant to the consulting agreements, the Company has agreed to issue 1,000,000 common shares to each of Pioneer Ventures Inc., Solar Properties Ltd., and Hilltop Business Center Inc. during the term of the agreements. Pioneer Ventures Inc., Solar Properties Ltd., and Hilltop Business Center Inc. are beneficially owned and controlled by two shareholders of the Company who own an aggregate of 5.1% of the common shares, common share purchase warrants, and incentive stock options exercisable into 700,000 common shares of the Company at a price of $0.75 per share. The consulting agreements with Pioneer Ventures Inc., Solar Properties Ltd., and Hilltop Business Center Inc. and the issuances of shares under these agreements are subject to regulatory approval.

The Company is also pleased to announce that it has settled $207,752.46 in outstanding debt through an issuance of common shares. In order to preserve its cash to fund its Nevada and Washington projects, the Company has issued a total of 288,702 common shares at a price of $0.70 per share to settle the debt of $207,752.46 through two separate creditors.

The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This news release does not constitute an offer for sale of securities for sale, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

For further information, please contact:

Linda Sampson
Chief Executive Officer & Director
Phone: 778-583-4476

ABOUT MARAPHARM VENTURES INC.
www.marapharm.com

Additional information on the operations or financial results of Marapharm are included in reports on file with applicable securities regulatory authorities and may be accessed through the CSE website (www.thecse.com), the OTC website (www.otcmarkets.com) and Sedar website (www.sedar.com) under the profile for Marapharm Ventures Inc.

FOR FURTHER INFORMATION:

www.marapharm.com or Linda Sampson, CEO, 778-583-4476

info@marapharm.com

STOCK EXCHANGES:

Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release.

FORWARD – LOOKING STATEMENTS:

Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, ‘may”, “will”, “project”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.

SOURCE: Marapharm Ventures Inc.

ReleaseID: 446294

LONDON, UK / ACCESSWIRE / September 30, 2016 / Active Wall St. announces its post-earnings coverage on Neogen Corp. (NASDAQ: NEOG). The company reported its financial results for the first quarter fiscal 2017 (Q1 FY17) on September 27th, 2016. The maker of medical testing kits announced that the reported quarter was the 98th of the past 103 quarters that Neogen posted revenue increases compared with the previous year, including all consecutive quarters in the last 11 years. Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its earnings coverage on NEOG. Get our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=NEOG.

Earnings Reviewed

For the three months period ended on 31st, August, 2016, Neogen reported revenues of $83.65 million, a 12% increase compared to revenues of $74.86 million in the year ago quarter; below analysts’ expectations of $86 million. During the reported quarter, the company’s net income increased 6% to $9.88 million, or $0.26 per share, compared to net income of $9.32 million, or $0.25 per share, in Q1 FY16. The company’s results surpassed Wall Street’s expectations of $0.25 per share. The revenues and net income represent first quarter records for Neogen.

“The first quarter was a good start for our 2017 fiscal year. We are where we want to be, and are continuing to establish our presence throughout our worldwide markets,” said James Herbert, Neogen’s chief executive officer and chairman.

Segment Results

During Q1 FY17, revenues for Neogen’s Food Safety segment increased 13% to $39.00 million on y-o-y basis, aided in part by the acquisitions of Lab M, acquired in August 2015, and Deoxi, purchased in April 2016. Sales of the Michigan-based company’s rapid tests for food allergens, such as gluten and peanuts, increased 17% in Q1 FY17, compared to the prior year. Overall organic growth for the Food Safety segment was 9% for Q1 FY17. In addition to the 55% improvement in sales of the company’s BioLumix and Soleris test systems, the company’s sales of its environmental sanitation testing products, which includes its AccuPoint® Advanced ATP Sanitation Monitoring System, increased 9% on y-o-y basis in Q1 FY17.

Neogen’s international operations continued to grow despite the impact of adverse currency translations. Revenues from Neogen’s Scotland-based subsidiary increased 24%, Mexico-based Neogen Latinoamerica’s sales increased 28%, Neogen do Brasil’s revenues increased 43%, and Neogen China’s sales increased 21%, all in U.S. dollars.

Neogen’s Animal Safety segment reported a revenue increase of 10% to $44.664 million, driven by acquisitions done within the past year. Sales of the company’s rodenticides increased approximately 17% in the reported quarter compared to Q1 FY16, and the company’s sales of rapid tests to detect drug residues in forensic samples increased 38% on y-o-y, attributed to new business in Brazil.

Operating Metrics

For Q1 FY17, Neogen’s gross margin was 48.4% of sales, compared to the 50.5% recorded in Q1 FY16. Factors contributing to the decline in gross margin included adverse currency translations, incremental revenue from acquisitions that have gross margins lower than the company’s historical average, and the loss of significant sales of a small animal supplement with a high margin that was removed from the market. Operating expenses increased 12% compared with Q1 FY16; operating income for Q1 FY17 was $14.74 million, or 17.6% of sales, compared to $14.90 million, or 19.9%, a year ago.

Balance Sheet

During Q1 FY17, Neogen generated $20.3 million in cash from operations aided by a 12% decrease in accounts receivable and an increase in accounts payable. The company invested $3.4 million in property and equipment during the reported quarter. Inventory balances increased $5.4 million from year-end levels as Neogen continue to work on minimizing back orders while also improving its inventory turnover. As of August 31st, 2016, Neogen had cash & investments worth $129.23 million compared to $107.80 million of cash & investments as of May 31st, 2016.

Stock Performance

On Thursday, September 29, 2016, Neogen’s shares were down 1.71%, finishing the day at $53.95 with volume of 179.17 thousand shares exchanging hands by the close of the trading session. The stock has advanced 10.10% and 19.92% in the last t six months and past twelve months, respectively. Shares of the company have a PE ratio of 55.91.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 446295

LONDON, UK / ACCESSWIRE / September 30, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Oil & Gas – E&P industry. Companies recently under review include Twin Butte Energy, Crew Energy, Canacol Energy, and Whitecap Resources. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

On Thursday, the Toronto Exchange Composite Index was up 0.16%, finishing the day at 14,754.55.

Additionally, the Energy index was up by 2.24%, ending the session at 199.89.

Active Wall St. has initiated research reports on the following equities: Twin Butte Energy Ltd. (TSX: TBE), Crew Energy Inc. (TSX: CR), Canacol Energy Ltd. (TSX: CNE), and Whitecap Resources Inc. (TSX: WCP). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Twin Butte Energy Ltd.

On Thursday, shares in Calgary, Canada headquartered Twin Butte Energy Ltd. recorded a trading volume of 8.46 million shares, which was higher than their three months average volume of 989,846 shares. The stock ended the day flat at $0.03. Shares of the Company, which engages in the acquisition, exploration, development, and production of petroleum and natural gas properties in Western Canada, are trading below its 50-day and 200-day moving averages. The stock’s 200-day moving average of $0.07 is above its 50-day moving average of $0.04. See our research report on TBE.TO at: http://www.activewallst.com/registration-3/?symbol=TBE.

Crew Energy Inc.

Calgary, Canada headquartered Crew Energy Inc.’s stock edged 0.44% higher, to finish Thursday’s session at $6.80 with a total volume of 1.14 million shares traded. Over the last one month and the previous three months, shares of Crew Energy, which engages in the acquisition, exploration, development, and production of crude oil and natural gas in Canada, have gained 3.50% and 17.04%, respectively. Furthermore, the stock has surged 57.41% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. Crew Energy’s 50-day moving average of $6.42 is above its 200-day moving average of $5.44. The complimentary research report on CR.TO at: http://www.activewallst.com/registration-3/?symbol=CR.

Canacol Energy Ltd.

Calgary, Canada headquartered Canacol Energy Ltd.’s stock edged 0.47% higher, to close the day at $4.31. The stock recorded a trading volume of 692,768 shares, which was above its three months average volume of 319,425 shares. Shares of Canacol Energy, which together with its subsidiaries, primarily engages in the exploration, development, and production of petroleum and natural gas in Colombia and Ecuador, have surged 63.26% in the previous one year. The company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $4.22 is greater than its 200-day moving average of $4.00. Register for free and access the latest research report on CNE.TO at: http://www.activewallst.com/registration-3/?symbol=CNE.

Whitecap Resources Inc.

On Thursday, shares in Calgary, Canada headquartered Whitecap Resources Inc. ended the session 4.67% higher at $11.20 with a total volume of 5.07 million shares traded. Shares of Whitecap Resources, which acquires, develops, optimizes, and produces crude oil and natural gas in western Canada, have gained 12.71% in the last one month and 14.16% in the previous three months. Further, the stock has advanced 6.71% in the past one year. The stock is trading above its 50-day and 200-day moving averages. The company’s 50-day moving average of $10.22 is greater than its 200-day moving average of $9.64. Get free access to your research report on WCP.TO at: http://www.activewallst.com/registration-3/?symbol=WCP.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 446299

BlackBerry also Announces Discontinuation of Handset Business

LONDON, UK / ACCESSWIRE / September 30, 2016 / Active Wall St. announces its post-earnings coverage on BlackBerry Limited (NASDAQ: BBRY). 

Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its earnings coverage on BBRY. Get our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=BBRY.

Earnings Reviewed

The company reported its fiscal 2017 second-quarter financial results on September 28th, 2016. The Canadian handset manufacturer reported narrower-than-expected loss while revenues at the software and services segment improved 111% reported a breakeven quarter and raised its full-year outlook.

For the quarter ended on August 31st, 2016, Blackberry reported a net loss of $372 million, or $0.71 per share, which included a $96 million inventory charge, compared to a net income of $51 million, or a loss of $0.24 per share, in the same period a year ago. Excluding non-recurring items, the company broke even on a per-share basis for the second consecutive quarter, beating analyst expectations for a loss of $0.5 per share. Revenue dropped to $334 million down 28.2% from $490 million last year, below analysts’ expectations of $392 million.

Segment Wise

During Q2 FY17, Blackberry’s total software services revenue came in at $156 million, up 111% on y-o-y basis, accounting for 44% of total sales; this was, however, down from $166 million reported in Q1 FY17. Roughly 81% of the Q2 FY17 software and services revenue was recurring. The company said it continues to expect revenue growth of 30% from software and services in FY 2017. For the reported quarter revenue from the Mobility solutions segment was $105 million and contributed approximately 30% of total sales. Blackberry generated Services access fees revenues of $91 million in Q2 FY17 and accounted for 26%. BlackBerry had around 3,000 enterprise customer wins in Q2 FY17.

On geographical basis, for Q2 FY17, North America contributed 56.9% to the total revenue of $334 million (on a reported basis), while Europe, the Middle East, and Africa accounted for 29.9%. Similarly, Latin America and the Asia/Pacific contributed 3.9% and 9.3%, respectively, in revenue during Q2 FY17.

Leadership Change

BlackBerry announced a change in senior leadership in a separate release on the same day. The company announced the departure of Chief Financial Officer, James Yersh, for personal reasons and appointed Steven Capelli as his replacement at the end of October. Capelli brings 25 years of executive experience in the software and technology industry. Most recently, Capelli was president of Worldwide Field Operations at Sybase with responsibility for $1 billion in annual revenue.

Balance Sheet

At the end of Q2 FY17, Blackberry had cash, cash equivalents, short-term and long-term investments of approximately $2.5 billion. Blackberry retired its convertible debt of 1.25 billion just after quarter end and replaced it with a convertible note of $605 million. By retiring the previous debt early, the company expects to save over 50 million a year in interest payments.

Operating Metrics

During Q2 FY17, Blackberry delivered the highest gross margin in the company history at 62%. This number was up from 53% in Q1 FY17 and 41% in the comparable quarter a year ago. This was attributed to an improvement in device margins and a more favorable revenue mix. Q2 FY17 operating income was $16 million. Blackberry achieved its eleventh consecutive quarter of positive EBITDA which came in at $45 million, translating to about 13% EBITDA margins.

Outlook

For FY17, BlackBerry expects adjusted earnings per share to be in the range of breakeven to a loss of $0.50 compared to analysts’ prediction of a loss of $0.16 per share.

The End of BlackBerry Phone

BlackBerry will no longer internally design or develop smartphone hardware. Instead, the company now intends to outsource hardware development to other partners. CEO John Chen says this will reduce the capital requirements of making phones while boosting return on invested capital. BlackBerry will shift to more of a royalty model, licensing its software and brand name out to other phone manufacturers.

“We are reaching an inflection point with our strategy,” said Chief Executive John Chen, “Our financial foundation is strong, and our pivot to software is taking hold.”

The company sold 400,000 devices in Q2 FY17, half what it sold in Q2 FY16. Apple sold 40.4 million units of iPhones in the previous quarter.

Licensing Agreement

BlackBerry announced an agreement with newly formed joint venture PT BB Merah Putih to license BlackBerry software and services for the production of handsets for the Indonesian market. This partnership will accelerate BlackBerry’s overall focus on driving software growth, specifically developing and licensing device software offerings, including security solutions and applications, through its Mobility Solutions business unit.

BB Merah Putih will source, distribute, and promote BlackBerry-branded devices that use BlackBerry’s secure Android software and applications. The joint venture and its affiliates account for nearly half of the total Indonesian mobile market.

Stock Performance

BlackBerry’s stock is trading tumbled 4.68%, closing Thursday’s session at $7.94 on volume of 11.35 million shares, which was above its 3-month average volume of 4.07 million shares. Shares of the company have surged 18.33% in the last three months. The company’s stock has a market cap of $4.19 billion as of Thursday’s closing bell.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 446302

LONDON, UK / ACCESSWIRE / September 30, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare Sector. Companies recently under review include Helius Medical Technologies, Aurinia Pharma, Telesta Therapeutics, and Aeterna Zentaris. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

At the close of the Canadian markets on Thursday, September 29, 2016, the Toronto Exchange Composite index ended the trading session at 14,754.55, 0.16% higher from its previous closing price.

The Healthcare Index was in the red, closing the day at 81.97, down 0.95%.

Active Wall St. has initiated research reports on the following equities: Helius Medical Technologies Inc. (TSX: HSM), Aurinia Pharmaceuticals Inc. (TSX: AUP), Telesta Therapeutics Inc. (TSX: TST), and Aeterna Zentaris Inc. (TSX: AEZ). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Helius Medical Technologies Inc.

On Thursday, shares in Newtown, Pennsylvania headquartered Helius Medical Technologies Inc. ended the session 3.85% higher at $1.35 with a total volume of 67,092 shares traded. Shares of Helius Medical Technologies, which operates as a medical technology company focused on neurological wellness, have gained 17.39% in the last one month. The stock is trading above its 50-day and 200-day moving averages. The company’s 200-day moving average of $1.28 is greater than its 50-day moving average of $1.23. See our research report on HSM.TO at: http://www.activewallst.com/registration-3/?symbol=HSM.

Aurinia Pharmaceuticals Inc.

Victoria, Canada headquartered clinical stage pharmaceutical company, Aurinia Pharmaceuticals Inc.’s stock gained 8.75%, to close the day at $3.48. The stock recorded a trading volume of 120,397 shares, which was above its three months average volume of 43,274 shares. Shares of Aurinia Pharmaceuticals, which engages in the development of a therapeutic drug to treat autoimmune diseases in Canada, have surged 35.94% in the previous one month. The company’s shares are trading above their 50-day moving average. Moreover, the stock’s 200-day moving average of $3.53 is greater than its 50-day moving average of $3.00. The complimentary research report on AUP.TO at: http://www.activewallst.com/registration-3/?symbol=AUP.

Telesta Therapeutics Inc.

Pointe-Claire, Canada headquartered biopharmaceutical company, Telesta Therapeutics Inc.’s stock finished Thursday’s session flat at $0.14 with a total volume of 326,602 shares traded. Shares of Telesta Therapeutics, which engages in the research, development, manufacture, and commercialization of human health products and technologies globally, have rallied 80.00% in the previous three months. The Company’s shares are trading above its 50-day and 200-day moving averages. Telesta Therapeutics’ 50-day moving average of $0.12 is above its 200-day moving average of $0.09. Register for free and access the latest research report on TST.TO at: http://www.activewallst.com/registration-3/?symbol=TST.

Aeterna Zentaris Inc.

On Thursday, shares in Summerville, South Carolina headquartered specialty biopharmaceutical company, Aeterna Zentaris Inc., recorded a trading volume of 7,919 shares. The stock ended the day 0.22% lower at $4.50. Shares of Aeterna Zentaris, which engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health, have advanced 6.38% in the past three months. The Company is trading below its 50-day and 200-day moving averages. The stock’s 50-day moving average of $4.63 is above its 200-day moving average of $4.60. Get free access to your research report on AEZ.TO at: http://www.activewallst.com/registration-3/?symbol=AEZ.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 446298

LONDON, UK / ACCESSWIRE / September 30, 2016 / Active Wall St. announces its post-earnings coverage on Paychex, Inc. (NASDAQ: PAYX). The company posted its financial results for the first quarter fiscal 2017 (Q1 FY17) on September 28, 2016. The Rochester, New York-based company’s Q1 FY17 total revenues grew 9% on y-o-y basis, while net income improved 4% y-o-y the reported quarter; both beating marketing expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its earnings coverage on PAYX. Get our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=PAYX.

Earnings Reviewed

In the quarter ended on August 31, 2016, Paychex’s reported total revenue of $785.5 million compared to total revenue of $723.0 million recorded at the end of Q1 FY16. Total revenue numbers underperformed market estimate of $782.8 million. The company’s total service revenue also grew 9.0% y-o-y in Q1 FY17 to $773.5 million from $712.2 million for the year-ago period.

The human resources services provider reported Q1 FY17 net income of $217.4 million, or $0.60 diluted per share, which was above $209.1 million, or $0.58 diluted per share, in the prior year’s comparable quarter and above market consensus estimates of $0.57 per diluted share. The company’s net income growth was positively impacted by 5% to 6% approximately improved results across business segments.

Martin Mucci, President and Chief Executive Officer of Paychex, said:

“We’re off to a solid start for fiscal 2017 with positive results across all major product lines. The number of client worksite employees served by our human resource outsourcing services grew by double digits over on a year-over-year basis.”

Operating Metrics

The company’s total expenses increased 8% y-o-y to $462.5 million in the reported quarter. The quarterly total expense growth was due to a 6% increase in compensation-related costs, primarily on higher wages due to an increased headcount in both operations and sales.

During Q1 FY17, the company’s operating income grew 9% y-o-y to $323.0 million from $296.1 million in the prior year’s comparable quarter. Furthermore, operating income as a percentage of total revenue came in at 41% similar to the figures recorded in the year ago period.

Segment-wise

Paychex’s Payroll service revenue grew 4% y-o-y to $450.9 million in Q1 FY17 from $432.5 million in Q1 FY16. The company attributed this growth to improved client base and revenue per check.

Due to increased client base across all major Human Resource Services segment, this segment’s revenue surged 15% y-o-y in Q1 FY17 to $322.6 million from $279.7 million in the prior year’s compatible quarter.

Cash Low and Balance Sheet

Paychex reported cash flow from operations improved 6% y-o-y to $294.7 million in Q1 FY17 from $278.3 million in Q1 FY16. The increased operating cash flow was primarily attributed to higher net income adjusted for non-cash items, partially offset by negative impacts of working capital fluctuations.

The company reported cash and cash equivalents balance of $130.0 million on August 31, 2016, compared to $131.5 million as on May 31, 2016. Paychex has not reported any long-term debt in its books of accounts as of August 31, 2016.

Outlook

For full year FY17, Paychex’s expects Payroll Service revenue to increase in the range of 3% to 4%. The company forecasts for an approximate 7% y-o-y growth in its net income for fiscal year ending May 31, 2017. The company’s management anticipates a 12% to 14% y-o-y growth in Human Resource Services revenue in FY17. Moreover, total service revenue is expected to increase in the range of 7% to 8% in the current fiscal year.

Stock Performance

Paychex’s share price finished yesterday’s trading session at $57.16, slightly sliding 0.59%. A total volume of 2.49 million shares exchanged hands, which was higher than the 3 months average volume of 2.13 million shares. The stock has advanced 7.19% and 24.01% in the last six months and past twelve months, respectively. Furthermore, since the start of the year, shares of the company has gained 10.78%. The stock is trading at a PE ratio of 27.38 and has a dividend yield of 3.22%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 446300

LONDON, UK / ACCESSWIRE / September 30, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the REITs industry. Companies recently under review include Milestone Apartments REIT, Pure Industrial RET, Crombie REIT, and Dream Global REIT. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

On Thursday at the end of trading session, the TSX Composite index closed at 14,754.55, 0.16% higher, on a total volume of 370,436,370 shares.

Active Wall St. has initiated research reports on the following equities: Milestone Apartments Real Estate Investment Trust (TSX: MST.UN), Pure Industrial Real Estate Trust (TSX: AAR.UN), Crombie Real Estate Investment Trust (TSX: CRR.UN), and Dream Global Real Estate Investment Trust (TSX: DRG.UN). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Milestone Apartments Real Estate Investment Trust

Toronto, Canada headquartered Milestone Apartments Real Estate Investment Trust’s stock edged 0.47% lower, to close the day at $19.22. The stock recorded a trading volume of 105,029 shares. Shares of Milestone Apartments Real Estate Investment Trust, which focuses on acquiring and owning multifamily properties in the US, have gained 2.57% in the last three months and 30.83% in the past one year. However, the stock has fallen by 2.58% in the previous one month. The company’s shares are trading above their 200-day moving average. Moreover, the stock’s 50-day moving average of $19.90 is greater than its 200-day moving average of $18.73. The Company’s shares traded at a PE ratio of 7.72. See our research report on MST-UN.TO at: http://www.activewallst.com/registration-3/?symbol=MST.UN.

Pure Industrial Real Estate Trust

Vancouver, Canada headquartered independent equity real estate investment trust, Pure Industrial Real Estate Trust’s stock finished Thursday’s session flat at $5.63 with a total volume of 272,361 shares traded. Over the last one month and the previous three months, Pure Industrial Real Estate Trust’s shares have advanced 2.29% and 11.00%, respectively. Furthermore, the stock has surged 36.06% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. Pure Industrial Real Estate Trust’s 50-day moving average of $5.58 is above its 50-day moving average of $5.18. Shares of the Company, which acquires, owns, and operates a diversified portfolio of income producing industrial properties in primary industrial markets, traded at a PE ratio of 8.47. The complimentary research report on AAR-UN.TO at: http://www.activewallst.com/registration-3/?symbol=AAR.UN.

Crombie Real Estate Investment Trust

On Thursday, shares in Stellarton, Canada based Crombie Real Estate Investment Trust ended the session 1.17% lower at $14.37 with a total volume of 199,697 shares traded. Crombie Real Estate Investment Trust’s shares have fallen by 4.93% in the last one month. However, the stock has gained 20.96% in the past one year. The stock is trading below its 50-day and 200-day moving averages. The company’s 50-day moving average of $15.10 is greater than its 200-day moving average of $14.84. Shares of Crombie Real Estate Investment Trust, which owns and manages commercial real estate properties in Atlantic Canada, traded at a PE ratio of 18.64. Register for free and access the latest research report on CRR-UN.TO at: http://www.activewallst.com/registration-3/?symbol=CRR.UN.

Dream Global Real Estate Investment Trust

On Thursday, shares in Toronto, Canada based Dream Global Real Estate Investment Trust recorded a trading volume of 264,304 shares. The stock ended the day flat at $9.03. Shares Dream Global Real Estate Investment Trust, which invests in real estate markets across the globe excluding Canada with a focus on Germany, has gained 1.31% in the last one month and 11.39% in the previous one year. The Company is trading above its 50-day and 200-day moving averages. The stock’s 200-day moving average of $9.01 is above its 50-day moving average of $8.99. Shares of the Company traded at PE ratio of 7.21. Get free access to your research report on DRG-UN.TO at: http://www.activewallst.com/registration-3/?symbol=DRG.UN.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 446297